Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Waeijen-Smit (Horn, Netherlands), N. Reynaert (Maastricht, Netherlands), R. Beijers (Maastricht, Netherlands), S. Houben-Wilke (Horn, Netherlands), S. Simons (Maastricht, Netherlands), M. Spruit (Horn, Netherlands), F. Franssen (Horn, Netherlands). Alterations of systemic hyaluronic acid in patients with COPD: a cross-sectional analysis. 667

Member's Comments

No comment yet.

Related content which might interest you: Relationship between plasma amino acid levels and lung function decline in patients with COPD Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Hyaluronic acid in COPD exacerbations of different etiology Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Local and systemic nucleic acid damage in COPD exacerbations. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Is hyaluronic acid (HA) a marker of effectiveness of anti-inflammatory therapy in COPD patients? Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Plasma amino acid profiles in patients of various respiratory disorders Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010 Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease? Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Serum levels of hyaluronic acid are associated with COPD severity and predict survival Source: Eur Respir J, 53 (3) 1801183; 10.1183/13993003.01183-2018 Year: 2019 Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018 Effect of nintedanib on hyaluronic acid metabolism in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Relationship of circulating hyaluronic acid levels to disease control in asthma and asthmatic pregnancy Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Serum uric acid levels among patients with COPD exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 33s Year: 2006 Amino acids and asthma: a case-control study Source: Eur Respir J 2004; 23: 565-568 Year: 2004 The effect of conjugated linoleic acid supplementation on the nutritional status of COPD patients Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Hyaluronic acid is significantly increased in idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 604s Year: 2006 Matrix metalloproteinase, hyaluronic acid and C-reactive protein: Are they really markers of lung obstruction at COPD but not cardiovascular comorbidity? Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Frequency of exacerbations in patients with COPD: an analysis of the SPIROMICS cohort Source: International Congress 2017 – COPD: latest insights into the management of patients Year: 2017 Assessment of serum uric acid in COPD exacerbations Source: International Congress 2017 – Markers of COPD progression Year: 2017 Patterns of pulmonary hypertension in Egyptian patients with COPD: A retrospective analysis Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021 Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Differential metabolism of hyaluronic acid in patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015